Sellas Life Sciences Stock Revenue
| SLS Stock | USD 1.13 0.04 3.42% |
Sellas Life Sciences fundamentals help investors to digest information that contributes to Sellas Life's financial success or failures. It also enables traders to predict the movement of Sellas Stock. The fundamental analysis module provides a way to measure Sellas Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sellas Life stock.
| Last Reported | Projected for Next Year |
Sellas | Revenue |
Sellas Life Sciences Company Revenue Analysis
Sellas Life's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Historical and Projected quarterly revenue of Sellas
Projected quarterly revenue analysis of Sellas Life Sciences provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Sellas Life match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Sellas Life's stock price.
Sellas Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Sellas Life is extremely important. It helps to project a fair market value of Sellas Stock properly, considering its historical fundamentals such as Revenue. Since Sellas Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Sellas Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Sellas Life's interrelated accounts and indicators.
| -0.26 | 0.16 | -0.42 | 0.11 | 0.25 | ||
| -0.26 | -0.15 | 0.39 | 0.38 | 0.16 | ||
| 0.16 | -0.15 | -0.57 | 0.59 | 0.3 | ||
| -0.42 | 0.39 | -0.57 | -0.27 | -0.05 | ||
| 0.11 | 0.38 | 0.59 | -0.27 | 0.3 | ||
| 0.25 | 0.16 | 0.3 | -0.05 | 0.3 |
Click cells to compare fundamentals
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Sellas Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Sellas Life Sciences reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
Sellas Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sellas Life's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sellas Life could also be used in its relative valuation, which is a method of valuing Sellas Life by comparing valuation metrics of similar companies.Sellas Life is currently under evaluation in revenue category among its peers.
Sellas Life Institutional Holders
Institutional Holdings refers to the ownership stake in Sellas Life that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Sellas Life's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Sellas Life's value.| Shares | Virtu Financial Llc | 2024-06-30 | 63.8 K | Xtx Topco Ltd | 2024-09-30 | 62.8 K | Springbok Capital Management, Llc | 2024-09-30 | 58.3 K | Lpl Financial Corp | 2024-09-30 | 51.9 K | Citadel Advisors Llc | 2024-09-30 | 47.3 K | Mariner Wealth Advisors Llc | 2024-06-30 | 44.9 K | Jane Street Group Llc | 2024-06-30 | 28 K | Two Sigma Investments Llc | 2024-09-30 | 16.6 K | Charles Schwab Investment Management Inc | 2024-09-30 | 16.2 K | Vanguard Group Inc | 2024-09-30 | 2.3 M | Anson Funds Management Lp | 2024-09-30 | 793.8 K |
Sellas Fundamentals
| Return On Equity | -8.88 | ||||
| Return On Asset | -1.29 | ||||
| Current Valuation | 59.08 M | ||||
| Shares Outstanding | 70.38 M | ||||
| Shares Owned By Insiders | 0.24 % | ||||
| Shares Owned By Institutions | 7.36 % | ||||
| Number Of Shares Shorted | 8.77 M | ||||
| Price To Book | 5.00 X | ||||
| Price To Sales | 26.90 X | ||||
| Gross Profit | 900 K | ||||
| EBITDA | 529 K | ||||
| Net Income | (37.34 M) | ||||
| Cash And Equivalents | 26.99 M | ||||
| Cash Per Share | 1.31 X | ||||
| Total Debt | 906 K | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 2.36 X | ||||
| Book Value Per Share | (0.25) X | ||||
| Cash Flow From Operations | (31.41 M) | ||||
| Short Ratio | 14.07 X | ||||
| Earnings Per Share | (0.67) X | ||||
| Target Price | 5.83 | ||||
| Number Of Employees | 16 | ||||
| Beta | 2.4 | ||||
| Market Capitalization | 82.35 M | ||||
| Total Asset | 6.22 M | ||||
| Retained Earnings | (217.24 M) | ||||
| Working Capital | (10.56 M) | ||||
| Net Asset | 6.22 M |
About Sellas Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sellas Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sellas Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sellas Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.